3.4 USD
-0.06 (-1.73%)
3.4 USD
0 (0%)
Overall LFMD gets a fundamental rating of 4 out of 10. We evaluated LFMD against 35 industry peers in the Health Care Technology industry. While LFMD seems to be doing ok healthwise, there are quite some concerns on its profitability. LFMD is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
LFMD had negative earnings in the past year.
In the past year LFMD had a positive cash flow from operations.
LFMD had negative earnings in each of the past 5 years.
In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
LFMD has a Return On Assets (-11.68%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -586.53%, LFMD is doing worse than 85.71% of the companies in the same industry.
The Return On Invested Capital of LFMD (5.81%) is better than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| ROIC | 5.81% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 0.27%, LFMD is doing good in the industry, outperforming 62.86% of the companies in the same industry.
LFMD has a better Gross Margin (86.96%) than 91.43% of its industry peers.
In the last couple of years the Gross Margin of LFMD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.27% | ||
| PM (TTM) | N/A | ||
| GM | 86.96% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LFMD is destroying value.
The number of shares outstanding for LFMD has been increased compared to 1 year ago.
Compared to 5 years ago, LFMD has more shares outstanding
Compared to 1 year ago, LFMD has an improved debt to assets ratio.
2.2 Solvency
LFMD has an Altman-Z score of -0.16. This is a bad value and indicates that LFMD is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.16, LFMD perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
LFMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | -0.16 |
ROIC/WACC0.57
WACC10.11%
2.3 Liquidity
A Current Ratio of 0.73 indicates that LFMD may have some problems paying its short term obligations.
The Current ratio of LFMD (0.73) is worse than 82.86% of its industry peers.
A Quick Ratio of 0.66 indicates that LFMD may have some problems paying its short term obligations.
LFMD has a Quick ratio of 0.66. This is amonst the worse of the industry: LFMD underperforms 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
LFMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.13%, which is quite impressive.
Looking at the last year, LFMD shows a very strong growth in Revenue. The Revenue has grown by 30.71%.
Measured over the past years, LFMD shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
3.2 Future
The Earnings Per Share is expected to grow by 18.36% on average over the next years. This is quite good.
LFMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y61.09%
EPS Next 2Y45.21%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 57.97, which means the current valuation is very expensive for LFMD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LFMD is on the same level as its industry peers.
LFMD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 57.97 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LFMD is valued a bit cheaper than 77.14% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFMD is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 662.66 | ||
| EV/EBITDA | 11.95 |
4.3 Compensation for Growth
LFMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LFMD's earnings are expected to grow with 34.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.21%
EPS Next 3Y34.41%
5. Dividend
5.1 Amount
No dividends for LFMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
3.4
-0.06 (-1.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners43.32%
Inst Owner Change-14.42%
Ins Owners17.88%
Ins Owner Change3.32%
Market Cap163.68M
Revenue(TTM)252.34M
Net Income(TTM)-7.71M
Analysts81.43
Price Target9.44 (177.65%)
Short Float %11.1%
Short Ratio3.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-40.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-341.17%
Min EPS beat(2)-635.29%
Max EPS beat(2)-47.05%
EPS beat(4)2
Avg EPS beat(4)-125.48%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-71.45%
EPS beat(12)4
Avg EPS beat(12)-68.84%
EPS beat(16)5
Avg EPS beat(16)-56.76%
Revenue beat(2)0
Avg Revenue beat(2)-6.5%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)-4.95%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.29%
Revenue beat(12)7
Avg Revenue beat(12)-0.23%
Revenue beat(16)7
Avg Revenue beat(16)-1.53%
PT rev (1m)-28.16%
PT rev (3m)-28.16%
EPS NQ rev (1m)13.04%
EPS NQ rev (3m)13.04%
EPS NY rev (1m)-50.73%
EPS NY rev (3m)-186.11%
Revenue NQ rev (1m)-22.99%
Revenue NQ rev (3m)-22.99%
Revenue NY rev (1m)-6.47%
Revenue NY rev (3m)-6.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 57.97 | ||
| P/S | 0.65 | ||
| P/FCF | 662.66 | ||
| P/OCF | 12.47 | ||
| P/B | 124.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.95 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.06
Fwd EY1.73%
FCF(TTM)0.01
FCFY0.15%
OCF(TTM)0.27
OCFY8.02%
SpS5.24
BVpS0.03
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| ROCE | 7.35% | ||
| ROIC | 5.81% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 0.27% | ||
| PM (TTM) | N/A | ||
| GM | 86.96% | ||
| FCFM | 0.1% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 116.91% | ||
| Cap/Sales | 5.1% | ||
| Interest Coverage | 0.33 | ||
| Cash Conversion | 112.17% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | -0.16 |
F-Score5
WACC10.11%
ROIC/WACC0.57
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y61.09%
EPS Next 2Y45.21%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
EBIT growth 1Y103.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.85%
EBIT Next 3Y55.58%
EBIT Next 5Y43.22%
FCF growth 1Y103.53%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y1051.68%
OCF growth 3YN/A
OCF growth 5Y133.93%
LIFEMD INC / LFMD FAQ
What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?
ChartMill assigns a fundamental rating of 4 / 10 to LFMD.
What is the valuation status of LIFEMD INC (LFMD) stock?
ChartMill assigns a valuation rating of 3 / 10 to LIFEMD INC (LFMD). This can be considered as Overvalued.
What is the profitability of LFMD stock?
LIFEMD INC (LFMD) has a profitability rating of 3 / 10.
What is the financial health of LIFEMD INC (LFMD) stock?
The financial health rating of LIFEMD INC (LFMD) is 4 / 10.
Can you provide the dividend sustainability for LFMD stock?
The dividend rating of LIFEMD INC (LFMD) is 0 / 10 and the dividend payout ratio is -40.3%.